2026 Fall Clinical Lipid Update Agenda

Thursday, October 1

Pre-Conference Courses (Separate Registration Required)
7:00 AM-6:00 PM

7:00 AM – 5:20 PM

Foundations of Lipidology Course

7:30 AM – 5:50 PM

Masters in Lipidology Course

10:00 AM – 4:00 PM

Triglyceride Masters Course

Friday, October 2

Pre-Conference Courses (Separate Registration Required)
7:00 AM-3:00 PM

7:00 AM – 1:00 PM

Foundations of Lipidology Course

7:30 AM – 2:45 PM

Masters in Lipidology Course

7:30 AM – 1:00 PM

Triglyceride Masters Course

SESSION I: Opening Session: High Risk, High Potential: The Clinical Significance of Lipoprotein(a)
4:00 PM-6:00 PM

4:00 PM – 4:10 PM

Welcome

4:10 PM – 4:15 PM

Pre-Session Assessment

4:15 PM – 4:35 PM

Pathophysiology, Genetic Architecture & Risk Stratification

Michael J. Wilkinson, MD, FNLA

4:35 PM – 4:55 PM

Clinical Management Today | What Can We Do Now?

Dinesh Kalra, MD, MBA, FNLA

4:55 PM – 5:15 PM

Emerging Therapies & Future Landscape

5:15 PM – 5:20 PM

Closing Remarks | Post-Session Assessment

5:20 PM – 5:40 PM

Roundtable Panel Discussion on Translating Lp(a) Science Into Clinical Algorithms

All Session Faculty

5:40 PM – 6:00 PM

Q&A Panel

Opening Night Exhibit Hall Kickoff Reception
6:00 PM-7:00 PM

Saturday, October 3rd

Expert Theaters | Breakfast Provided
8:05 AM – 8:55 AM

Breakfast
8:00 AM-9:00 AM

Opening Remarks
8:50 AM-9:00 AM

SESSION II: Guideline Discussion
9:00 AM-10:50 AM

9:00 AM – 9:05 AM

Pre-Session Assessment

9:05 AM – 9:25 AM

The PREVENT Era

9:25 AM – 9:45 AM

ApoB and Lp(a) Integration

Jelani K. Grant, MD, FNLA

9:45 AM – 10:05 AM

Target-based Management: The “Cholesterol-Years Model”

10:05 AM – 10:25 AM

Subclinical Atherosclerosis Imaging

10:25 AM – 10:50 AM

Q&A Panel | Post-Session Assessment

Break
10:50 AM-11:20 AM

SESSION III: Clinical Trials
11:20 AM-12:50 PM

11:20 AM – 11:25 AM

Pre-Session Assessment

11:25 AM – 11:45 AM

Recap: Developing Clinical Trials From the Past Year

Kevin Maki, PhD, CLS, MNLA

11:45 AM – 12:05 PM

What’s In the Pipeline? The CORAL Reef Clinical Trial

Alberico L. Catapano, PhD

12:05 PM – 12:25 PM

Practical Application of Trial Data to Practice

Kaye-Eileen Willard, MD, FNLA

12:25 PM – 12:50 PM

Q&A Panel | Post-Session Assessment

Expert Theaters | Lunch Provided
12:55 PM-1:45 PM

Lunch
12:50 PM-1:50 PM

SESSION IV: Lipid Scholar Case Discussion
1:50 PM-2:55 PM

1:50 PM – 1:55 PM

Pre-Session Assessment

1:55 PM – 2:05 PM

Case Discussion I

2:05 PM – 2:15 PM

Case Discussion II

2:15 PM – 2:35 PM

Case Discussion III

2:35 PM – 2:55 PM

Q&A | Post-Session Assessment

Break
2:55 PM-3:25 PM

SESSION V: Controversies of the 2025-2030 Dietary Guidelines | Examining the Evidence
3:25 PM-5:15 PM

3:25 PM – 3:30 PM

Pre-Session Assessment

3:30 PM – 3:40 PM

Overview of the 2025-2030 Dietary Guidelines for Americans

Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA

3:40 PM – 4:00 PM

Protein: Its Role in Cardiometabolic Health

4:00 PM – 4:20 PM

Clearing Up the Confusion About Seed Oils and Healthy Fats

Kristina S. Petersen, PhD

4:20 PM – 4:40 PM

Is There Room for Full-Fat Dairy in a Heart-Healthy Dietary Pattern?

4:40 PM – 4:50 PM

Comparing the 2025-2030 DGAs to the NLA’s Nutrition Interventions for Dyslipidemia Management

Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA

4:50 PM – 5:15 PM

Q&A Panel | Post-Session Assessment

Sunday, October 4th

Breakfast
8:00 AM-9:00 AM

SESSION VI: Impact of Statin Reluctance and Lipid Lowering Myths in Patient Treatment
9:00 AM-10:30 AM

9:00 AM – 9:05 AM

Pre-Session Assessment

9:05 AM – 9:25 AM

Addressing Statin & Lipid Lowering Reluctance (Pharmacologic Myths)

Alexander Turchin, MD, MS

9:25 AM – 9:45 AM

Neuroprotection vs. Neurophobia

9:45 AM – 10:05 AM

Shared Decision Making

10:05 AM – 10:30 AM

Q&A Panel | Post-Session Assessment

Break
10:30 AM-10:45 AM

SESSION VII: Lifespan Lipidology | Pregnacy → Pediatrics → Adulthood → Geriatrics
10:45 AM-12:35 PM

10:45 AM – 10:50 AM

Pre-Session Assessment

10:50 AM – 11:10 AM

The 2026 AHA Statement on Pediatric SHTG: Standardizing the Diagnosis and Treatment of Pediatric Hypertriglyceridemia

Nivedita Patni, MD

11:10 AM – 11:30 AM

Pregnancy and Cardiovascular Risk

Erin Michos, MD, MHS

11:30 AM – 11:50 AM

Adulthood; Use of Polygenic Risk Scores

11:50 AM – 12:10 PM

Geriatrics

Vera Bittner, MD, MSPH, MNLA

12:10 PM – 12:35 PM

Q&A Panel | Post-Session Assessment

Adjourn
12:35 PM